Skip to main content

clog-free filtersfor bioreactors

“We lose yield in membrane filters. This could be huge.” – MNC R&D Lead.“Dead cell removal during perfusion? Game-changing.” – Biotech Stakeholder.“We're always looking for clean, scalable alternatives.” – CDMO Director.

Clogging Kills Continuity

Membrane filters foul during runs, causing interruptions, yield loss, and emergency cleanups.

Impurities Compromise Safety

Residual Host Cell Proteins (HCPs) can escape membranes, reducing product purity and risking downstream compliance.

Downtime Costs Millions

Every cleaning cycle, membrane replacement, or run stoppage bleeds revenue, especially in high-throughput lines.

Benefits

  • ultra-high cell density
  • dead cell removal
  • lower HCPs
  • higher yield
  • higher purity

Technology

inertial microfluidics

A mixed population enters the spiral unfocused. Inertial lift and Dean drag carry each cell to an equilibrium position set by its size: larger live cells to the inner wall, smaller dead cells and debris to the outer wall. A splitter at the core separates the two streams. No membrane, nothing to foul.

Live cells
inner wall → back to the bioreactor
Dead cells & debris
outer wall → waste

What We Stand ForInnovation. Precision. Performance.

At CelltoMix, we are redefining bioprocessing through next-generation microfluidic technology. Founded by leading scientists and engineers, our mission is to solve the industry's toughest filtration challenges, starting with clog-free, high-yield microfilters.

With a science-first approach and over two decades of international research experience behind our core team, we're building tools that increase cell culture productivity, reduce operational downtime, and optimize bioreactor performance.

We believe innovation in life sciences begins at the microscopic level, and that's exactly where we thrive.

Our TeamPrecision. Expertise. Global excellence.

Portrait of Dr. Shireen Goh

Dr. Shireen Goh

scientific advisor & founder

Dr. Shireen Goh is scientific co-founder of Celltomix and Associate Professor at SUTD, specializing in microfluidics and biomanufacturing with technologies licensed to industry, including Erbi Biosystems (acquired by Merck in 2022).

The bench

  • Dr. Danny van Noort
  • Leo Siang Kwong
  • Pranav Garg
  • Siggy

50+ years of combined experience in technology, smart manufacturing, automation, microtechnology, bioengineering, physics and strategic marketing.

  • Portrait of Dr. Danny van Noort

    Dr. Danny van Noort

    Co-Founder

    Dr. Danny van Noort is an internationally recognized researcher with 25+ years of experience in physics, microtechnology, and biomedical engineering. He specializes in biosensors, DNA computers, organ-on-chips, and 3D cell models, with numerous publications and global lectures.

  • Portrait of Leo Siang Kwong

    Leo Siang Kwong

    Co-Founder

    Leo Siang Kwong is an expert in digital transformation and automation, with 25+ years of experience in technology and engineering. A certified PMP and ScrumMaster, he specializes in leading large-scale digital initiatives, smart manufacturing, and ERP solutions, translating business vision into scalable innovation.

  • Portrait of Pranav Garg

    Pranav Garg

    Co-Founder

    Pranav Garg is a young co-founder with a strong foundation in marketing and entrepreneurship. As the founder of a successful marketing firm in India, he specializes in strategic marketing and business development, driving growth and innovation in his ventures.

  • Portrait of Siggy

    Siggy

    Chief Morale Officer

    Siggy supervises from above, contributes no code, and has never missed a standup that coincided with lunch.

  • Join The CelltoMix NewsletterBe the first to receive the latest news and updates.

    Yes, subscribe me to your newsletter.

    Signups open soon. Email cell2mix.contact@gmail.com in the meantime.